We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Beta Cell Function in Women With Turner Syndrome

This study has been terminated.
(Completed)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00419107
First Posted: January 8, 2007
Last Update Posted: November 8, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Aarhus
January 5, 2007
January 8, 2007
November 8, 2011
November 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00419107 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Beta Cell Function in Women With Turner Syndrome
Beta Cell Function in Women With Turner Syndrome
Diabetes is more frequent in women with Turner syndrome. The purpose of this study is to see, in what ways the glucose metabolism is different in this study population. The hypothesis is that women with Turner Syndrome have an impaired insulin production (beta cell function).
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Blood samples.
Non-Probability Sample
13 women with TS and 12 control women
Turner Syndrome
Not Provided
Not Provided
Hjerrild BE, Holst JJ, Juhl CB, Christiansen JS, Schmitz O, Gravholt CH. Delayed β-cell response and glucose intolerance in young women with Turner syndrome. BMC Endocr Disord. 2011 Mar 15;11:6. doi: 10.1186/1472-6823-11-6.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
25
January 2007
Not Provided

Inclusion Criteria:

  • Turner syndrome

Exclusion Criteria:

  • Diagnosed diabetes
  • BMI>30
  • Untreated cardiac or thyroid disease
  • Cancer illness
Sexes Eligible for Study: Female
20 Years to 40 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00419107
20040108
Not Provided
Not Provided
Not Provided
Jens Sandahl Christiansen, Aarhus University Hospital, Aarhus, Denmark
University of Aarhus
Not Provided
Principal Investigator: Jens Sandahl Christiansen, prof. dr.med
University of Aarhus
November 2011